T cells

BIOLOGICAL3 trials

Sponsors

University of Pennsylvania, Karolinska University Hospital, Academisch Medisch Centrum

Conditions

Graft-versus-host disease Graft-versus-host reactionHIV-1 InfectionsMelanoma

Phase 1

CD4-ZETA Gene Modified T Cells With and Without Exogenous Interleukin-2 (IL-2) In HIV Patients

CompletedNCT01013415

University of PennsylvaniaHIV-1 Infections

Start: 2001-09-30End: 2021-08-31Updated: 2022-08-19

T Cell Transfer With or Without Dendritic Cell Vaccination in Patients With Melanoma

Karolinska University HospitalMelanoma

Start: 2013-10-31End: 2025-12-31Target: 20Updated: 2022-10-04

Unknown Phase

T cells and innate lymphoid cells (ILCs) in cutaneous graft-versus-host disease

Academisch Medisch CentrumGraft-versus-host disease Graft-versus-host reaction

Target: 20Updated: 2024-02-28

Related Papers

Investigation of cell therapies: a role for TIL and/or DC vaccines?

South East European Journal of Immunology2025-03-25

Complete and long-lasting clinical responses in immune checkpoint inhibitor-resistant, metastasized melanoma treated with adoptive T cell transfer combined with DC vaccination

OncoImmunology2020-01-0147 citations

A phase I study of adoptive T-cell therapy with or without dendritic cell vaccination in patients with metastatic melanoma.

Journal of Clinical Oncology2014-05-201 citations